Finance

Lists
950220:KOSDAQ
Neoimmunetech Inc
â‚©2,575.00
+7.74%
(+185.00) 1D
Sep 4, 3:30:28 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 950220...
Open
â‚©2,405
High
â‚©2,575
Low
â‚©2,310
Mkt. cap
79.88B
Avg. vol.
1.59M
Volume
449.06K
52-wk high
â‚©4,790
52-wk low
â‚©501
EPS
-â‚©1,300
Shares outstanding
34.21M
No. of employees
52
Open
â‚©2,405
High
â‚©2,575
Low
â‚©2,310
Mkt. cap
79.88B
Avg. vol.
1.59M
Volume
449.06K
52-wk high
â‚©4,790
52-wk low
â‚©501
EPS
-â‚©1,300
Shares outstanding
34.21M
No. of employees
52
About Neoimmunetech Inc
CEOSe Hwan Yang
Employees52
Founded2014
HeadquartersRockville, Maryland, United States
SectorBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
18.33M
38.78M
533.70M
1.17B
Cost of goods sold
-
-
-
250.09M
Cost of revenue
-
-
-
250.09M
Research and development expenses
-
-
3.67B
2.10B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.91B
5.52B
2.74B
2.47B
Operating expense
4.52B
6.28B
6.86B
5.16B
Total operating expenses
4.52B
6.28B
6.86B
5.41B
Operating income
-4.51B
-6.24B
-6.33B
-4.24B
Other non operating income
-1.33B
-1.58B
-655.65M
4.25B
EBT including unusual items
-5.83B
-10.68B
-7.64B
-447.40M
EBT excluding unusual items
-5.83B
-10.85B
-7.64B
-424.56M
Income tax expense
-24.86M
38.56M
-
-1.14M
Effective tax rate
0.43%
-0.36%
-
0.25%
Other operating expenses
-
-
-
-
Net income
-5.81B
-10.72B
-7.64B
-446.26M
Net profit margin
-31,682.28%
-27,627.98%
-1,431.91%
-38.16%
Earnings per share
-
-
-
-
Interest and investment income
-
1.26B
406.72M
369.46M
Interest expense
-
-2.42B
-621.13M
-601.63M
Net interest expenses
-
-1.17B
-214.41M
-232.17M
Depreciation and amortization charges
433.28M
432.76M
218.96M
204.10M
EBITDA
-4.51B
-5.62B
-5.70B
-3.47B
Gain or loss from assets sale
-
-213.95M
-
24.48M
AI content may include mistakes. Learn more
Google apps